Such PNP inhibitors have been investigated as potential treatments for the uncontrolled T and B cell proliferation seen in leukemia, autoimmune diseases, transplant rejection, and graft vs. host disease (41, 42). This evidence concerns the gene PNP and glycogen storage disease VI.